March 05, 2026

What Prevents Chemo-Linked HFS?

Network meta-analysis compares preventive agents for chemotherapy-induced hand-foot syndrome

Conexiant

March 05, 2026

Calcium Strategy Following Thyroidectomy

Investigators compare routine prophylaxis vs postoperative parathyroid hormone-guided supplementation.

Conexiant

March 05, 2026

Why One Number Isn’t Enough for Patients

Adding a comparison number may help patients interpret risk and make better decisions.

Conexiant

March 02, 2026

GLP-1–Progestin and Endometrial Cancer Risk

Adjunct therapy tied to fewer cancers and hysterectomies.

Conexiant

February 26, 2026

Most Salivary Gland Neoplasms Found to Be Benign in Single-Center Study

Analysis of 50 cases shows moderate diagnostic agreement between FNAC and histopathology and identifies pleomorphic adenoma as the most common neoplasm.

Conexiant

February 25, 2026

AI Tools Expand in Thyroid Cancer Diagnosis

Uptake will require “compelling evidence that these systems can reduce time and effort while at least maintaining, if not improving, diagnostic accuracy, making the cost of implementation and continued usage worthwhile.”

Conexiant

February 19, 2026

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.

Conexiant

February 17, 2026

Exercise Matters Following Cancer

Postdiagnosis physical activity was associated with lower cancer mortality across several cancer types.

Conexiant

February 13, 2026

Primary Care’s Rug Pulled Out?

CMS abruptly scraps a 10-year primary care model, leaving nearly 700 practices rethinking staffing, funding, and patient access.

KFF Health News

February 12, 2026

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

Conexiant